Back

Practical value and external validation of the PRECISE-DAPT cancer score in patients with acute myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: global clinical challenges Stratification, Prevention and Monitoring ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mohamed Dafaalla

University Hospital of North Midlands, Stoke-on-Trent (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Elevated remnant cholesterol and increased risk of colorectal cancer and atherosclerotic cardiovascular diseases: a prospective cohort study
Miss Y. Xiao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Effects on cardiotoxicity of CT-P6 Biosimilars vs Trastuzumab among adults with breast cancer: a systematic review and meta-analysis
Doctor F. Santoceldes (Taguig, PH)
Abstract Slides Video
Presentation thumbnail
Effects of chemoradiotherapy on the cardiac and aortic glucose metabolism in patients with advanced non-small cell lung cancer
Doctor P. Khaing (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Real-world analysis of risk factors for cardiovascular toxicity associated with immune checkpoint inhibitors
Professor R. Asteggiano (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Immune checkpoint inhibitor associated myocarditis - lessons from a case series
Mrs M. Prieto (Dresden, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology: global clinical challenges

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic role of PRECISE-DAPT score in acute coronary syndrome: insight from sigle centre registry
thumbnail
Congress Presentation
External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients
thumbnail
Congress Presentation
Prolonged dual antiplatelet therapy in an extended Phase 3 Cardiac Rehabilitation Program following myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources